1. Home
  2. SCLX vs MLGO Comparison

SCLX vs MLGO Comparison

Compare SCLX & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.48

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

Logo MicroAlgo Inc.

MLGO

MicroAlgo Inc.

BUY

Current Price

$4.34

Market Cap

44.0M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
SCLX
MLGO
Founded
2011
2018
Country
United States
China
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
44.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SCLX
MLGO
Price
$6.48
$4.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
92.4K
92.9K
Earning Date
04-10-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$87,132,230.00
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
$0.91
Revenue Growth
N/A
6.21
52 Week Low
$4.09
$0.50
52 Week High
$34.27
$21.18

Technical Indicators

Market Signals
Indicator
SCLX
MLGO
Relative Strength Index (RSI) 39.05 59.78
Support Level $6.20 $4.30
Resistance Level $8.18 $4.47
Average True Range (ATR) 1.38 0.32
MACD -0.32 0.03
Stochastic Oscillator 1.16 71.23

Price Performance

Historical Comparison
SCLX
MLGO

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About MLGO MicroAlgo Inc.

MicroAlgo Inc is engaged in the development and application of bespoke central processing algorithms and provides solutions by integrating these algorithms with software or hardware, or both, to streamline digital services. Its services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Its technology and solutions are mainly in internet multimedia video advertising, where it provides advertising distribution solutions, software services, comprehensive solutions for enterprise customers, and intelligent chips solutions. It derives revenue from central processing algorithm services for internet advertisement and intelligent chips and services, with maximum revenue generated from Mainland PRC.

Share on Social Networks: